The American Dermatologic Shirt Surgery Action Group (ASDS) has circulated its evidence-based recommendations for physicians performing injectable filling procedures. The guide, published in a February 2021 issue of Dermatologic Surgery, specifically addressing the prevention and treatment of adverse events from injectable filling therapies.
Evidence-based clinical guidelines provide an essential resource for physicians, and ASDS seeks to be recognized as the authoritative source on the science of surgical intervention treatment of skin age and skin disease. We have gathered the best available evidence within the scientific literature to form the basis for best practice in patient care for soft tissue filler injections. “
Derek Jones, MD, Chair, ASDS Software Fillers Management Action Group
The multidisciplinary task force was formed in 2018 and consisted of ASDS member physicians (eight boards certified in dermatology, two in plastic and reconstructive surgery, one in ophthalmology ), two patient and procedure representatives:
- Derek Jones, MD, Chairman
- Murad Alam, MD, MBA
- Kimberly Butterwick, MD
- Jean Carruthers, MD (Oculoplastic Surgery)
- Sue Ellen Cox, MD
- Steve Dayan, MD (Facial Plastic Surgery)
- Lisa Donofrio, MD
- Rebecca Fitzgerald, MD
- Shannon Humphrey, MD, FRCPC
- Nowell Solish, MD
- Jackie Yee, MD (Physics)
- M. Hassan Murad, MD, MPH, Methodologist
- Shari Weiss, Patient Representative
- Lisa O’Keefe, Patient Representative
Using the Levels of Recommendations, Evaluation, Development and Evaluation (GRADE) approach, the task group identified six essential questions to focus the guidance and inform the literature review. The questions quantified risk factors for vascular occlusion; treatments for blindness; treatment of vascular occlusion of the skin without blindness; risk factors for nodules and inflammatory events with hyaluronic acid nets; treatments for nodules and inflammatory events; and risk factors for nodules and inflammatory events from non-hyaluronic acid fillers.
ASDS commissioned the Mayo Clinic Evidence-Based Practice Center to conduct systematic reviews to extract the data and summarize the relevant evidence. The guide sets out suggestions for:
- Prevention of vascular occlusion, blindness, stroke.
- Treatment of vascular occlusion associated with blind filling.
- Treatment of vascular (skin) occlusion without blindness.
- Treatment of nodules and inflammatory events from hyaluronic acid nets.
- Treatment of nodules caused by permanent and semi-permanent nets.
Source:
American Society for Dermatologic Surgery (ASDS)